follow us:Google+ FacebookLinkedInTwitterRSS Feeds


Antares Pharma enters marketing agreement worth up to $20M for psoriasis treatment


Back to Top Comments Email Print

News You Can Use

Latest News


    Ewing-based Antares Pharma Inc. announced today its exclusive promotion and marketing agreement with Denmark-based LEO Pharma regarding the latter company's Otrexup psoriasis treatment.

    According to the announcement, Antares will receive a $5 million initial payment and up to $15 million in additional milestone payments. Antares Pharma will record all product revenue associated with future dermatology prescriptions and pay LEO Pharma a percentage of Otrexup net sales generated in dermatology. LEO Pharma will be responsible for promotion and marketing activities in dermatology.

    Antares appointed a new senior vice president for medical earlier this month.

    Share This Story On:

    Write to the Editorial Department at



    Be the first to comment.

    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    Back to Top